StockData
Apimeds Pharmaceuticals US, Inc. logo

Apimeds Pharmaceuticals US, Inc. (APUS) stock

APUSNYSEPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 1/30
$1.95−0.09 (-4.41%)

Close on Nov 17, 2026Market cap $2.94MP/E –Yield –

Apimeds Pharmaceuticals US enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

Apimeds Pharmaceuticals US's enterprise value was $3.28M on Nov 11, 2026, against $29.48M a year earlier.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$3.28M-75.9%
2025Dec 31, 2025$13.64M–

More Apimeds Pharmaceuticals US figures

See a number that looks wrong?